158 related articles for article (PubMed ID: 25161890)
1. Peroxisome proliferator-activated receptor gamma (PPARG) modulates free fatty acid receptor 1 (FFAR1) dependent insulin secretion in humans.
Wagner R; Hieronimus A; Lamprinou A; Heni M; Hatziagelaki E; Ullrich S; Stefan N; Staiger H; Häring HU; Fritsche A
Mol Metab; 2014 Sep; 3(6):676-80. PubMed ID: 25161890
[TBL] [Abstract][Full Text] [Related]
2. Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humans.
Wagner R; Kaiser G; Gerst F; Christiansen E; Due-Hansen ME; Grundmann M; Machicao F; Peter A; Kostenis E; Ulven T; Fritsche A; Häring HU; Ullrich S
Diabetes; 2013 Jun; 62(6):2106-11. PubMed ID: 23378609
[TBL] [Abstract][Full Text] [Related]
3. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects.
Ruchat SM; Weisnagel SJ; Vohl MC; Rankinen T; Bouchard C; Pérusse L
Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736
[TBL] [Abstract][Full Text] [Related]
4. Lack of GPR40/FFAR1 does not induce diabetes even under insulin resistance condition.
Matsuda-Nagasumi K; Takami-Esaki R; Iwachidow K; Yasuhara Y; Tanaka H; Ogi K; Nakata M; Yano T; Hinuma S; Taketomi S; Odaka H; Kaisho Y
Diabetes Obes Metab; 2013 Jun; 15(6):538-45. PubMed ID: 23331570
[TBL] [Abstract][Full Text] [Related]
5. Free fatty acid receptor 1 (FFAR1/GPR40) signaling affects insulin secretion by enhancing mitochondrial respiration during palmitate exposure.
Kristinsson H; Bergsten P; Sargsyan E
Biochim Biophys Acta; 2015 Dec; 1853(12):3248-57. PubMed ID: 26408932
[TBL] [Abstract][Full Text] [Related]
6. Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance.
Sabrautzki S; Kaiser G; Przemeck GKH; Gerst F; Lorza-Gil E; Panse M; Sartorius T; Hoene M; Marschall S; Häring HU; Hrabě de Angelis M; Ullrich S
Mol Metab; 2017 Oct; 6(10):1304-1312. PubMed ID: 29031729
[TBL] [Abstract][Full Text] [Related]
7. A novel free fatty acid receptor 1 (GPR40/FFAR1) agonist, MR1704, enhances glucose-dependent insulin secretion and improves glucose homeostasis in rats.
Tsuda N; Kawaji A; Sato T; Takagi M; Higashi C; Kato Y; Ogawa K; Naba H; Ohkouchi M; Nakamura M; Hosaka Y; Sakaki J
Pharmacol Res Perspect; 2017 Aug; 5(4):. PubMed ID: 28805970
[TBL] [Abstract][Full Text] [Related]
8. Mice Lacking Free Fatty Acid Receptor 1 (GPR40/FFAR1) are Protected Against Conjugated Linoleic Acid-Induced Fatty Liver but Develop Inflammation and Insulin Resistance in the Brain.
Sartorius T; Drescher A; Panse M; Lastovicka P; Peter A; Weigert C; Kostenis E; Ullrich S; Häring HU
Cell Physiol Biochem; 2015; 35(6):2272-84. PubMed ID: 25895678
[TBL] [Abstract][Full Text] [Related]
9. A FFAR1 full agonist restores islet function in models of impaired glucose-stimulated insulin secretion and diabetic non-human primates.
Rady B; Liu J; Huang H; Bakaj I; Qi J; Lee SP; Martin T; Norquay L; Player M; Pocai A
Front Endocrinol (Lausanne); 2022; 13():1061688. PubMed ID: 36482991
[TBL] [Abstract][Full Text] [Related]
10. Recent Updates on Free Fatty Acid Receptor 1 (GPR-40) Agonists for the Treatment of Type 2 Diabetes Mellitus.
Rani L; Grewal AS; Sharma N; Singh S
Mini Rev Med Chem; 2021; 21(4):426-470. PubMed ID: 33100202
[TBL] [Abstract][Full Text] [Related]
11. Lack of FFAR1/GPR40 does not protect mice from high-fat diet-induced metabolic disease.
Lan H; Hoos LM; Liu L; Tetzloff G; Hu W; Abbondanzo SJ; Vassileva G; Gustafson EL; Hedrick JA; Davis HR
Diabetes; 2008 Nov; 57(11):2999-3006. PubMed ID: 18678612
[TBL] [Abstract][Full Text] [Related]
12. Activation of extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) by free fatty acid receptor 1 (FFAR1/GPR40) protects from palmitate-induced beta cell death, but plays no role in insulin secretion.
Panse M; Gerst F; Kaiser G; Teutsch CA; Dölker R; Wagner R; Häring HU; Ullrich S
Cell Physiol Biochem; 2015; 35(4):1537-45. PubMed ID: 25792236
[TBL] [Abstract][Full Text] [Related]
13. A novel antidiabetic drug, fasiglifam/TAK-875, acts as an ago-allosteric modulator of FFAR1.
Yabuki C; Komatsu H; Tsujihata Y; Maeda R; Ito R; Matsuda-Nagasumi K; Sakuma K; Miyawaki K; Kikuchi N; Takeuchi K; Habata Y; Mori M
PLoS One; 2013; 8(10):e76280. PubMed ID: 24130766
[TBL] [Abstract][Full Text] [Related]
14. Synthetic GPR40/FFAR1 agonists: An exhaustive survey on the most recent chemical classes and their structure-activity relationships.
Paul A; Nahar S; Nahata P; Sarkar A; Maji A; Samanta A; Karmakar S; Maity TK
Eur J Med Chem; 2024 Jan; 264():115990. PubMed ID: 38039791
[TBL] [Abstract][Full Text] [Related]
15. Suppression of free fatty acid receptor 1 expression in pancreatic β-cells in obese type 2 diabetic db/db mice: a potential role of pancreatic and duodenal homeobox factor 1.
Kohara K; Obata A; Kimura T; Shimoda M; Moriuchi S; Okauchi S; Hirukawa H; Mune T; Kaku K; Kaneto H
Endocr J; 2019 Jan; 66(1):43-50. PubMed ID: 30333365
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of insulin secretion by acetylenic fatty acids in insulinoma MIN6 cells through FFAR1.
Nishino K; Uesugi H; Hirasawa A; Ohtera A; Miyamae Y; Neffati M; Isoda H; Kambe T; Masuda S; Irie K; Nagao M
Biochem Biophys Res Commun; 2020 Jan; 522(1):68-73. PubMed ID: 31740001
[TBL] [Abstract][Full Text] [Related]
17. Basal hypersecretion of glucagon and insulin from palmitate-exposed human islets depends on FFAR1 but not decreased somatostatin secretion.
Kristinsson H; Sargsyan E; Manell H; Smith DM; Göpel SO; Bergsten P
Sci Rep; 2017 Jul; 7(1):4657. PubMed ID: 28680093
[TBL] [Abstract][Full Text] [Related]
18. Identification of an Orally Efficacious GPR40/FFAR1 Receptor Agonist.
Agarwal S; Sasane S; Deshmukh P; Rami B; Bandyopadhyay D; Giri P; Giri S; Jain M; Desai RC
ACS Med Chem Lett; 2016 Dec; 7(12):1134-1138. PubMed ID: 27994752
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of fatty acid activation of FFAR1.
Kumari P; Inoue A; Chapman K; Lian P; Rosenbaum DM
Proc Natl Acad Sci U S A; 2023 May; 120(22):e2219569120. PubMed ID: 37216523
[TBL] [Abstract][Full Text] [Related]
20. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
Ylönen SK; Salminen I; Lyssenko V; Virtanen SM; Groop L; Aro A; Saloranta C;
Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]